American pharmaceutical companies are increasingly seeking medicines from China, with a surge in deals involving Chinese companies. This trend is driven by China's development of effective molecules at lower costs, reshaping the biopharma sector. Despite uncertainties, experts predict continued growth in deal activity in the pharmaceutical sector.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay